- Home
- GAIA vs FBRX Comparison
GAIA vs FBRX Comparison
Compare GAIA & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAIA
- FBRX
- Stock Information
- Founded
- GAIA 1988
- FBRX N/A
- Country
- GAIA United States
- FBRX United States
- Employees
- GAIA N/A
- FBRX N/A
- Industry
- GAIA Movies/Entertainment
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- GAIA Consumer Discretionary
- FBRX Health Care
- Exchange
- GAIA Nasdaq
- FBRX Nasdaq
- Market Cap
- GAIA 142.6M
- FBRX 154.5M
- IPO Year
- GAIA 1999
- FBRX N/A
- Fundamental
- Price
- GAIA $5.57
- FBRX $10.92
- Analyst Decision
- GAIA Strong Buy
- FBRX Strong Buy
- Analyst Count
- GAIA 2
- FBRX 3
- Target Price
- GAIA $8.00
- FBRX $68.00
- AVG Volume (30 Days)
- GAIA 37.3K
- FBRX 63.8K
- Earning Date
- GAIA 11-03-2025
- FBRX 08-14-2025
- Dividend Yield
- GAIA N/A
- FBRX N/A
- EPS Growth
- GAIA N/A
- FBRX N/A
- EPS
- GAIA N/A
- FBRX N/A
- Revenue
- GAIA $95,666,000.00
- FBRX N/A
- Revenue This Year
- GAIA $13.81
- FBRX N/A
- Revenue Next Year
- GAIA $15.74
- FBRX N/A
- P/E Ratio
- GAIA N/A
- FBRX N/A
- Revenue Growth
- GAIA 13.74
- FBRX N/A
- 52 Week Low
- GAIA $2.93
- FBRX $4.11
- 52 Week High
- GAIA $6.53
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- GAIA 59.69
- FBRX 48.35
- Support Level
- GAIA $5.49
- FBRX $10.65
- Resistance Level
- GAIA $5.79
- FBRX $11.57
- Average True Range (ATR)
- GAIA 0.25
- FBRX 0.93
- MACD
- GAIA -0.02
- FBRX -0.04
- Stochastic Oscillator
- GAIA 59.70
- FBRX 19.22
About GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).